General Western Blot Reagents
Abcam Metronidazole, Antiparasitic and antibacterial compound, 25G
MW 171.15 Da, Purity >99%. Nitroimidazole compound with antiparasitic and antibacterial activity. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Mebendazole, Benzimidazole antihelmintic, 5G
MW 295.29 Da, Purity >99%. Benzimidazole antihelmintic. Tubulin-disrupting drug. Antitumour activity in vitro and in vivo. Inhibits growth and induces apoptosis.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SR 59230A hydrochloride, beta3 adrenoceptor antagonist, 50MG
MW 361.9 Da, Purity >99%. Potent, selective β3 adrenoceptor antagonist (IC50 values are 40, 408 and 648 nM for β3, β1 and β2, respectively). Orally active *in vivo*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-Oleoylethanolamine, PPAR-alpha agonist, 100MG
MW 325.5 Da, Purity >98%. Potent PPAR-α agonist (EC₅₀ = 120 nM). Anandamide (ab120087, ab120429) analog. Binds to cannabinoid receptor GPR119. Shows anti-ischemic and neuroprotective effects in vivo. Orally active.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Dienogest, Steroidal progesterone, 100MG
MW 311.4 Da, Purity >99%. Steroidal progesterone. Non-ethinylated progestin structurally related to testosterone. Anti-androgenic and antiproliferative effects in vitro.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Voriconazole (UK-109, 496), anti-fungal agent, 10MG
MW 349.31 Da, Purity >99%. Potent and broad-spectrum anti-fungal agent. Inhibits CYP450-dependent 14-α sterol demethylase, to interfere with ergosterol biosynthesis and inhibit fungal growth. Active in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Fluconazole, Cytochrome P450 inhibitor, 50MG
MW 306.27 Da, Purity >99%. Triazole antifungal agent. Cytochrome P450 inhibitor (IC₅₀ values are 30.3, 12.3, 13.1 μM for CYP2C9, CYP2C19 and CYP3A4, respectively). Penetrates the blood-brain barrier.
The product is subject to the following: Abcam Restricted Use Statement
Abcam ML-9, protein kinase inhibitor, 10MG
MW 361.3 Da, Purity >98%. Broad spectrum ATP-competitive protein kinase inhibitor (Ki values are 32, 4, and 54 μM for PKA, MLCK, and PKC respectively). Ca²+ channel blocker. Shows vasorelaxant effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam NADNADH Assay Kit (Fluorometric)
NADNADH Assay Kit (Fluorometric)
The product is subject to the following: Abcam Restricted Use Statement
Abcam N-Acetylphytosphingosine (NAPS), Sphingolipid ceramide derivative, 5MG
MW 359.5 Da, Purity >98%. Sphingolipid ceramide derivative. Induces caspase-dependent apoptosis. Anticancer agent. Potential NF-κB and JAK/STAT signaling inhibitor. Active in vitro and potentially in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bis(3,5-dibromosalicyl) fumarate, hemoglobin acylating agent, 100MG
MW 671.9 Da, Purity >93%. Potent hemoglobin acylating agent. Cross-links beta chains of hemoglobin. Acylating and anti-sickling agent. Active in vitro and in vivo.
The product is subject to the following: Abcam Restricted Use Statement
Abcam RGD (Arg-Gly-Asp), sequence involved in cell adhesion, 25MG
MW 346.34 Da, Purity >95%. RGD (Arg-Gly-Asp), sequence involved in cell adhesion. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Aeroplysinin (Aeroplysinin-1), antiangiogenic agent, 1MG
MW 338.98 Da, Purity >95%. Potent antiangiogenic agent. Inhibits COX-2 expression. Selectivity for endothelial cells. Able to induce apoptosis via capsase activation, chromatin condensation and nuclear fragmentation. Antibiotic and cytotoxic effects (IC₅₀ = 3 μm) and displays a wide-spectrum antitumor activity. Active in vivo. .
The product is subject to the following: Abcam Restricted Use Statement
Abcam D-erythro-Dihydrosphingosine-1-phosphate, sphingosine 1-phosphate receptor ligand, 5MG
MW 381.5 Da, Purity >98%. Sphingosine 1-phosphate (S1P) receptor ligand (Ki = 15 nM). May be used as negative control for intracellular effects of S1P (ab141748). Anti-fibrotic effect in fibroblasts.
The product is subject to the following: Abcam Restricted Use Statement